WHERE YOU CAN FIND MORE INFORMATION
Available Information
We are required to
file periodic reports, proxy statements and other information relating to our business, financial and other matters with the SEC under the Securities Exchange Act of 1934, as amended (the Exchange Act). Our filings are available to the
public over the Internet at the SECs web site at http://www.sec.gov. Our reports, proxy statements and other information relating to us can also be read and copied at the New York Stock Exchange, or NYSE, located at 11 Wall St., New York, New
York 10005, (212) 656-3000. Our common stock is listed on the NYSE under the symbol ALB.
We make available, free of charge, on or through our web site, copies of our Annual Reports on Form
10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K and amendments to those reports filed or furnished
pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file them with or furnish them to the SEC. We maintain a web site at http://www.albemarle.com. The information on our web site is
not, and shall not be deemed to be, part of this prospectus supplement, the accompanying prospectus or the registration statement, and our web address is included in this prospectus as an inactive textual reference only.
Incorporation by Reference
The SEC
allows us to incorporate by reference the information that we file with the SEC. This allows us to disclose important information to you by referring to those filed documents. Any information referred to in this way is considered part of
this prospectus supplement and the accompanying prospectus, except for any information that is superseded by information that is included directly in this prospectus supplement and the accompanying prospectus, and any information that we file with
the SEC after the date of this prospectus supplement will automatically update and supersede this information.
We are incorporating by
reference the documents listed below and all documents that we file after the date of this prospectus supplement with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of the securities covered
by this prospectus supplement. These additional documents include periodic reports, such as annual reports on Form 10-K, quarterly reports on Form 10-Q and current
reports on Form 8-K (other than information furnished under Items 2.02 and 7.01, which is deemed not to be incorporated by reference in this prospectus supplement or the accompanying prospectus), as well as
proxy statements. You should review these filings as they may disclose a change in our business, prospects, financial condition or other affairs after the date of this prospectus supplement. This prospectus supplement and the accompanying prospectus
incorporate by reference the documents listed below that we have filed with the SEC but have not been included or delivered with this document:
(a) Annual Report on Form
10-K for the fiscal year ended December 31, 2021, filed on February
22, 2022, as amended by Amendment No. 1 thereto filed with the SEC on March 2, 2022.
(b) Proxy Statement on Form DEF
14A filed on March
22, 2022.
(c) Quarterly Report on Form
10-Q for the quarter ended March 31, 2022, filed on May 4, 2022.
(d) Current
Reports on Form 8-K filed on February
18, 2022, February
24, 2022, February
28, 2022, March
9, 2022, and May 4, 2022 (reporting Item 5.07).
We are not, however, incorporating by reference any documents or portions thereof, whether specifically listed above or filed in the future,
that are not deemed filed with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K or certain exhibits furnished pursuant to Item 9.01 of Form 8-K.
S-38